Stephenson Global Pancreatic Cancer Research Institute

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

Our mission is to end pancreatic cancer by funding groundbreaking and innovative research, accelerating scientific discoveries, and fostering collaboration to advance early detection and transformative treatments.

Stephenson Global Pancreatic Cancer Research Institute (SGPCRI) has been established to advance early detection, innovative treatments and breakthrough research for pancreatic cancer. Inspired by the legacy of Toni Stephenson, SGPCRI strives to accelerate life-altering scientific and medical advances in pancreatic cancer to significantly reduce death rates, ease the burden on patients and their families, and ultimately eradicate the disease.

SGPCRI is redefining the research landscape with a groundbreaking model designed for agility and rapid progress. The pillars of the SGPCRI include the Stephenson Global Prize, the Stephenson Global Scholar Grants and the Annual Stephenson Pancreatic Cancer Symposium.

Stephenson Global Prize

A $1 million annual award, recognizing individuals whose groundbreaking contributions have significantly advanced pancreatic cancer research, bringing us closer to the ultimate goal of eradication.

Stephenson Global Scholar Grants

Stephenson Global Scholar Grants empower investigators to pursue bold and innovative ideas, providing substantial funding to fuel transformative research. By cutting through bureaucracy and eliminating red tape, the SGPCRI creates an environment that encourages true innovation and courageous risk-taking.

Leadership

“As entrepreneurs, we know that innovative thinking can solve a multitude of complex problems. The path to success was never found by following a standard line of thinking. We have always directed our leadership teams to question our methods, and if it appears we need to turn another way — especially toward transformation — we must chart a new course and get to it.”

Co-founders

A. Emmet Stephenson Jr. and Tessa Stephenson Brand

Meet the Executive and Advisory Boards

Learn about the leaders driving SGPCRI’s mission.

News and Press

The Stephenson Global Pancreatic Cancer Research Institute Launches First-of-Its-Kind Global Scientific Awards to Advance Breakthrough Discovery in Pancreatic Cancer

February 13, 2025 - The Stephenson Global Pancreatic Cancer Research Institute (SGPCRI) is creating transformative new programs in a groundbreaking search for a cure for pancreatic cancer.

How City Of Hope Is Forging New Frontiers In Pancreatic Cancer Research, Fueled By a Historic $150 Million Gift

November 19, 2024 - In a historic gift, Emmet and Tessa bestowed $150 million — equivalent to two-thirds of the total allotted budget for pancreatic cancer research from the National Cancer Institute — to City of Hope.

Inside the Institutes: City of Hope Receives $150 Million Gift to Advance Pancreatic Cancer Research

October 08, 2024 - The $150 million gift was provided by entrepreneurs and philanthropists A. Emmet Stephenson Jr. and his daughter Tessa Stephenson Brand in honor of Toni Stephenson who passed away from pancreatic cancer.

Father-Daughter Duo Gives $150 Million for Pancreatic Cancer Research

September 23, 2024 - Emmet Stephenson Jr. and his daughter are giving the money to honor his late wife, Toni Stephenson, who died from pancreatic cancer in 2020.